Project #83: CD318 orchestrates immune regulation and supports beta-cell function in T1D
Forecasted
This grant funds early-career researchers studying how CD318 regulates immunity and supports beta-cell function in type 1 diabetes, aiming to uncover new therapeutic strategies.
Funder: Diabetes Research Connection
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: Up to $75,000 per project; typically a one-year award.
Summary: Supports early-career researchers investigating immune regulation and beta-cell function in type 1 diabetes.
Key Information: This is a forecasted opportunity; all dates are projected.
Description
This Diabetes Research Connection grant supports innovative research into the mechanisms of immune regulation and beta-cell function in type 1 diabetes (T1D). The featured project explores the role of CD138, a molecule expressed by both beta cells and immune cells, in modulating inflammation and autoimmunity. The goal is to uncover new therapeutic strategies that protect beta cells and reduce autoimmune attacks, ultimately improving outcomes for people with T1D. The program emphasizes support for early-career scientists pursuing novel, peer-reviewed research relevant to T1D.
